Arrowhead Pharmaceuticals Inc (ARWR)
CapEx to Revenue
5.12%
Quarterly · Period ending:
ARWR CapEx to Revenue
Latest reported5.12%period ending
Latest reported5.12%period ending
ARWR Quarterly CapEx/Revenue (0.00% → 5.12%)
Latest values, visible window
High-resolution chart · PNG
ARWR capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 5.1214% | |
| 3.4786% | |
| 0.8135% | |
| 2.92% | |
| 8.5137% | |
| 0.976% | |
| 300.64% | |
| 0% | |
| 0% | |
| 0% | |
| 1,933.4272% | |
| 397.0119% | |
| 294.5024% | |
| 18.6741% | |
| 62.2118% | |
| 103.5978% | |
| 29.4212% | |
| 3.1303% | |
| 21.0576% | |
| 21.4168% | |
| 8.5659% | |
| 21.8402% | |
| 20.0488% | |
| 24.6874% | |
| 7.8098% | |
| 15.3385% | |
| 14.6664% | |
| 18.0883% | |
| 7.5498% | |
| 0.4347% | |
| 2.1279% | |
| 6.3036% | |
| 27.2294% | |
| 58.1896% | |
| 3.8581% | |
| 1.233% | |
| 12.3906% | |
| 15.0959% | |
| 121.3299% | |
| 8,679.9648% | |
| 1,634.8281% | |
| 214.9074% | |
| 929.3989% | |
| 1,908.4823% | |
| 229.162% | |
| 679.1269% | |
| 325.0044% | |
| 1,063.7143% | |
| 1,472.4914% | |
| 1,123.5589% | |
| 265.6343% | |
| 35.9291% | |
| 366.144% | |
| 50.352% | |
| 5.9359% | |
| 198.6537% | |
| 241.1649% | |
| 665.0112% | |
| 289.7738% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0.4612% | |
| 0% | |
| 4.0044% | |
| -292.9446% | |
| 65.1122% | |
| 25.7515% | |
| 41.6407% | |
| 33.3302% | |
| 65.9437% | |
| 0% | |
| 1,042.0032% | |
| 784.565% | |
| 126.5355% | |
| 380.0504% | |
| 38.2749% | |
| 0% | |
| 137.5727% | |
| 119.6099% | |
| 292.099% | |
| 278.9763% | |
| 573.9086% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |